Artificial Intelligence Across the Cardiac Amyloidosis Diagnostic and Management Pathway: From Single-Modality Detection to Multimodal Clinical Integration

Cardiac amyloidosis (CA) is increasingly recognized but remains substantially underdiagnosed because its clinical and imaging phenotype overlaps with more common cardiomyopathies. Definitive subtype assignment and management further require integration of multimodal evidence to distinguish transthyr